LivaNova PLC - Ordinary Shares (NQ:LIVN)

75.07 +0.37 (+0.50%)

Delayed Quote Updated: 4:00 PM EDT, Oct 2, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about LivaNova PLC - Ordinary Shares

< Previous 1 2 3 4 5 6 7 Next >

LivaNova Shares Move Higher On Street-Beating Q3 Earnings ↗

November 03, 2021

LivaNova PLC (NASDAQ: LIVN) posted Q3 sales of $253.2 million, +5.5% Y/Y on a reported basis and 5% on a constant-currency basis, beating the consensus of $245.27...

Via Benzinga

LivaNova PLC (LIVN) Q3 2021 Earnings Call Transcript ↗

November 03, 2021

LIVN earnings call for the period ending September 30, 2021.

Via The Motley Fool

Topics Earnings

LivaNova Reports Third Quarter 2021 Results

November 03, 2021

From LivaNova PLC

Via Business Wire

LivaNova to Host Conference Call for Third Quarter 2021 Results

October 04, 2021

From LivaNova PLC

Via Business Wire

LivaNova to Present at the Baird 2021 Global Healthcare Conference

August 26, 2021

From LivaNova PLC

Via Business Wire

LivaNova's Earnings: A Preview ↗

July 27, 2021

LivaNova (NASDAQ:LIVN) will be releasing its next round of earnings this Wednesday, July 28. For all of the relevant information, here is your guide for Wednesday's Q2 earnings...

Via Benzinga

Recap: LivaNova Q1 Earnings ↗

April 28, 2021

Shares of LivaNova (NASDAQ:LIVN) were unchanged after the company reported Q1 results. Quarterly Results Earnings per share rose 6.06% year over year to $0.35, which beat...

Via Benzinga

10 Biggest Price Target Changes For Friday ↗

August 20, 2021

Raymond James boosted the price target on The Estée Lauder Companies Inc. (NYSE:

Via Benzinga

LivaNova Announces Early Retirement of $450 Million Term Loan and Executes $125 Million Revolving Credit Facility

August 16, 2021

From LivaNova PLC

Via Business Wire

Looking into LivaNova's Return on Capital Employed ↗

August 04, 2021

Pulled from Benzinga Pro data LivaNova (NASDAQ:LIVN) reported Q2 sales of $264.50 million. Earnings fell to a loss of $34.86 million, resulting in a 819.09% decrease from last...

Via Benzinga

LivaNova Prices Offering of Ordinary Shares

August 03, 2021

From LivaNova PLC

Via Business Wire

LivaNova Announces Offering of Ordinary Shares

August 02, 2021

From LivaNova PLC

Via Business Wire

LivaNova PLC (LIVN) Q2 2021 Earnings Call Transcript ↗

July 28, 2021

LIVN earnings call for the period ending June 30, 2021.

Via The Motley Fool

Topics Earnings

LivaNova Reports Second Quarter 2021 Results and Appoints Alex Shvartsburg as Chief Financial Officer

July 28, 2021

From LivaNova PLC

Via Business Wire

What Does LivaNova's Debt Look Like? ↗

July 26, 2021

Shares of LivaNova (NASDAQ:LIVN) fell by 3.55% in the past three months. Before having a look at the importance of debt, let us look at how much debt LivaNova has. LivaNova...

Via Benzinga

Benzinga's Top Ratings Upgrades, Downgrades For July 20, 2021 ↗

July 20, 2021

Upgrades For Bank of Marin Bancorp (NASDAQ:

Via Benzinga

LivaNova to Host Conference Call for Second Quarter 2021 Results

June 28, 2021

From LivaNova PLC

Via Business Wire

LivaNova Receives FDA Approval for Clinical Study to Evaluate the aura6000 System to Treat Obstructive Sleep Apnea

June 15, 2021

From LivaNova PLC

Via Business Wire

LivaNova Completes Initial Closing of Heart Valve Business to Gyrus Capital

June 01, 2021

From LivaNova PLC

Via Business Wire

LivaNova to Present at the UBS Global Healthcare Virtual Conference

May 13, 2021

From LivaNova PLC

Via Business Wire

LivaNova PLC (LIVN) Q1 2021 Earnings Call Transcript ↗

April 28, 2021

LIVN earnings call for the period ending March 31, 2021.

Via The Motley Fool

Topics Earnings

LivaNova Reports First Quarter 2021 Results

April 28, 2021

From LivaNova PLC

Via Business Wire

LivaNova and Verily Announce First Patient Enrolled in Study to Evaluate Treatment Effectiveness for Patients Living with Depression

April 26, 2021

From LivaNova PLC

Via Business Wire

LivaNova Receives FDA 510(k) Clearance for B-Capta, the New In-Line, Blood-Gas Monitoring System Integrated Into the S5 Heart-Lung Machine

April 20, 2021

From LivaNova PLC

Via Business Wire

LivaNova Achieves Clinical Milestone in Heart Failure Program

April 19, 2021

From LivaNova PLC

Via Business Wire

10 Biggest Price Target Changes For Tuesday ↗

April 13, 2021

Rosenblatt boosted NVIDIA Corporation (NASDAQ: NVDA) price target from $700 to $800. NVIDIA shares fell 0.2% to $607.00 in pre-market trading. Keybanc boosted the price target...

Via Benzinga

< Previous 1 2 3 4 5 6 7 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io. Quotes delayed at least 20 minutes. Market data may be delayed. Research information, not personalized advice.